Cytosorbents
CTSO
#9450
Rank
A$81.55 M
Marketcap
$1.48
Share price
2.22%
Change (1 day)
-5.50%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2024 (TTM): -A$29.08 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$33.79 Million. In 2023 the company made an earning of -A$47.31 Million, an increase over its 2022 earnings that were of -A$54.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$29.08 Million-38.52%
2023 -A$47.31 Million-13.52%
2022 -A$54.7 Million34.04%
2021 -A$40.81 Million182.17%
2020 -A$14.47 Million-55.97%
2019 -A$32.85 Million14.17%
2018 -A$28.77 Million95.14%
2017 -A$14.75 Million-22.32%
2016 -A$18.98 Million39.1%
2015 -A$13.65 Million-12.89%
2014 -A$15.66 Million89%
2013 -A$8.29 Million26.65%
2012 -A$6.55 Million-26.02%
2011 -A$8.85 Million-288.45%
2010 A$4.69 M-4.17%
2009 A$4.89 M-287.19%
2008 -A$2.62 Million-47.12%
2007 -A$4.95 Million41.78%
2006 -A$3.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$89.54 M-384.88%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.59 B-5,166.80%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.55 B-11,401.75%๐Ÿ‡บ๐Ÿ‡ธ USA